In this study, we examined the effects of ibogaminalog (DM506), a nonhallucinogenic analog of ibogamine, in a mouse model of chemotherapy-induced...
Array
(
[id_prestablog_news] => 2475
[id_shop] => 1
[date] => 2026-05-01 00:00:00
[date_modification] => 2026-05-01 00:00:00
[langues] => ["1","2"]
[actif] => 1
[slide] => 0
[url_redirect] =>
[average_rating] =>
[number_rating] =>
[author_id] => 1
[featured] => 0
[ishero] => 0
[prim_key] => 4818
[id_lang] => 2
[title] => Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuro
[paragraph] => Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in Mice | ACS Chemical Neuroscience
[content] => Authors
Jason Younkin, Eda Koseli, Belle Buzzi, Edward Choi, Torin Honaker, Randall L. Davis, Dina Manetti, Maria Novella Romanelli, Aysel Cetinkaya-Fisgin, Hugo R. Arias, Ahmet Hoke, Javier Gonzalez-Maeso, M. Imad Damaj
Lab
Journal
ACS Chemical Neuroscience
Abstract
In this study, we examined the effects of ibogaminalog (DM506), a nonhallucinogenic analog of ibogamine, in a mouse model of chemotherapy-induced peripheral neuropathy (CIPN) induced by paclitaxel. We also assessed the effects of tabernanthalog (TBG) and investigated the potential role of serotonin receptor subtype 2A (5-HT2AR) for both compounds. DM506 and TBG demonstrated antinociceptive activity in the CIPN model. DM506 produced a more prolonged effect, lasting between 10 and 14 days, with nociception reduction in mechanical (von Frey) and cold (acetone) hypersensitivity assays. These effects were observed in a dose- and time-dependent manner. Unlike some previous studies that reported effects lasting only hours, the effects we observed persisted for several days. Furthermore, neither compound produced long-lasting effects on locomotor activity, even at relatively high doses. The antinociceptive effects of both compounds in the CIPN mouse model were blocked by the 5-HT2AR selective antagonist volinanserin.In vitrostudies revealed that DM506 does not block cytokine/chemokine expression in microglial cells but partially protected dorsal root ganglion (DRG) neurons treated with paclitaxel in the 100–300 nM concentration range in a volinanserin-sensitive manner. We conclude that DM506 and TBG possess antinociceptive properties in mice via pathways involving 5-HT2AR activation. Although it is unlikely that this effect involves anti-inflammatory activity in microglia, partial neuroprotective activity in DRG neurons can be considered.
Keywords/Topics
ibogalogs; chronic pain; neuropathy; 5-HT2AR; mice; chemotherapy
[meta_description] =>
[meta_keywords] => https://pubs.acs.org/doi/abs/10.1021/acschemneuro.5c01002
[meta_title] =>
[link_rewrite] => Activity-of-Nonhallucinogenic-Ibogalogs-on-Chemotherapy-Induced-Peripheral-Neuropathic-Pain-in-Mice-|-ACS-Chemical-Neuroscience
[actif_langue] => 1
[read] => 0
[count_comments] => 0
[id] => 2475
[categories] => Array
(
[29] => Array
(
[id_prestablog_categorie] => 29
[title] => Douleurs neuropathiques
[link_rewrite] => Douleurs-neuropathiques
)
[2] => Array
(
[id_prestablog_categorie] => 2
[title] => Publications
[link_rewrite] => publications
)
)
[authors] =>
[paragraph_crop] => Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in [...]
[link_for_unique] => 1
[products_liaison] => Array
(
[1206] => Array
(
[name] => Cages de contention modulables pour rats et souris
[description_short] => Nouvelles cage de contention modulables ROBUSTES pour maintenir doucement les rongeurs (rats et souris) durant les protocoles d'évaluation de la douleur, comme Hargreaves et Von Frey: un design innovant, pratique, solide et ergonomique de Bioseb.
[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://bioseb.com/fr/douleur-allodyniehyperalgesie-mecanique/1206-modular-holder-cages-for-rats-and-mice.html
)
)
)
1 En lire plus